研究業績

学会発表:2005年

掲載日:2011年03月25日

国際学会

  1. Nagoshi Y, Kuwasako K, Cao Y-N, Imamura T, Kitamura K, Eto T: Effects of C-reactive protein on atherogenic mediators and adrenomedullin in human coronary artery endothelial smooth muscle cells. 54th Annual Scientific Session, American College of Cardiology, 2005-3 (Orlando, USA)
  2. Nakamura R, Kato J, Kitamura K, Imamura T, Onitsuka H, Cao Y-N, Eto T: Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. 54th Annual Scientific Session, American College of Cardiology, 2005-3 (Orlando, USA)
  3. Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao Y-N, Imamura T, Kitamura K, Asada Y, Eto T: Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensinII-induced hypertensive rats. 54th Annual Scientific Session, American College of Cardiology, 2005-3 (Orlando, USA)
  4. Kuwasako K, Kitamura K, Cao Y-N, Nagoshi Y, Eto T: Characterization of the human CGRP receptor subtypes associated with receptor activity-modifying proteins. 20th Annual Scientific Meeting of the American Society of Hypertension, 2005-5 (San Francisco, USA)
  5. Kuwasako K, Kitamura K, Cao Y-N, Nagoshi Y, Eto T: Identification of dominant-negative human RAMP1 able to inhibit endogenous CGRP1 receptor function. 20th Annual Scientific Meeting of the American Society of Hypertension, 2005-5 (San Francisco, USA)
  6. Masuyama H, Tsuruda T, Kato J, Imamura T, Asada Y, Stasch JP, Eto T: Beneficial effect of soluble guanylate cyclase stimulator BAY41-2272 on cardiovascular remodeling in angiotensin II-induced hypertensive rats. 2nd International Conference on cGMP, 2005-6 (Potsdam, Germany)
  7. Masuyama H, Tsuruda T, Kato J, Imamura T, Asada Y, Stasch JP, Eto T: Soluble guanylate cyclase stimulator BAY41-2272 ameliorates cardiovascular remodeling in angiotensin II-induced hypertensive rats. 15th European Meeting on Hypertension, 2005-6 (Milan, Italy)
  8. Tsuruda T, Kato J, Matsui E, Hatakeyama K, Masuyama H, Imamura T, Kitamura K, Asada Y, Eto T: Adrenomedullin alleviates not only neointimal formation but also perivascular hyperplasia following arterial injury in rats. 15th European Meeting on Hypertension, 2005-6 (Milan, Italy)
  9. Kato J, Kitamura K, Eto T: Plasma adrenomedullin level as a predictor of development of hypertension. 59th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in Association with the Council on Kidney in Cardiovascular Disease, 2005-9 (Washington DC, USA)
  10. Cao Y-N, Kuwasako K, Kato J, Nishihira K, Kita T, Eto T, Kitamura K: Establishment of proadrenomedullin N-terminal 20 peptide (PAMP) transgenic rat and the novel functions of PAMP. 7th Japan-China Joint Hypertension Symposium, 2005-9 (Asahikawa, Japan)
  11. Tsuruda T, Kato J, Hatakeyama K, Imamura T, Kitamura K, Nakamura K, Asada Y, Eto T: Antifibrotic effect of mast cells-derived adrenomedullin in abdominal aortic aneurysm. American Heart Association Scientific Sessions 2005, 2005-11 (Dallas, USA)

国内学会

  1. 桑迫健二、北村和雄、江藤胤尚:1型CGRP受容体を構成する受容体活性調節蛋白1(RAMP1)の構造・活性相関およびその受容体の機能を抑制するdominant-negative RAMP1 の同定.第34回日本心脈管作動物質学会、2005年2月(京都)
  2. 桑迫健二、北村和雄、江藤胤尚:1型CGRP受容体の機能を抑制するdominant-negative RAMP1 の同定.第78回日本薬理学会年会、2005年3月(横浜)
  3. Cao Y-N, Kitamura K, Kuwasako K, Kato J, Nishihira K, Asada Y, Eto T: Inhibited cardiac hypertrophy in proadrenomedullin NH2-Terminal 20 peptide-transgenic rat with unilateral nephrectomy and high salt loading. 第69回日本循環器学会総会、2005年3月(横浜)
  4. Tsuruda T, Kato J, Matsui E, Hatakeyama K, Masuyama H, Imamura T, Kitamura K, Asada Y, Eto T: Adrenomedullin alleviates not only neointimal formation but also perivascular hyperplasia following arterial injury in rats.第69回日本循環器学会総会、2005年3月(横浜)
  5. 加藤丈司、北村和雄、江藤胤尚:降圧ペプチドの血中濃度と高血圧発症.第28回日本高血圧学会総会、2005年9月(旭川)
  6. 増山浩幸、鶴田敏博、加藤丈司、今村卓郎、浅田祐士郎、Stasch JP, 江藤胤尚:可溶性グアニル酸シクラーゼ刺激による高血圧ラットの心線維化抑制効果:アンジオテンシンII type 1 受容体の役割.第28回日本高血圧学会総会、2005年9月(旭川)
  7. 加藤丈司、北村和雄、江藤胤尚:原発性アルドステロン症患者(PA)の前負荷や後負荷と血中ANPおよびBNP濃度.第9回日本心血管内分泌代謝学会総会、2005年11月(東京)
  8. 桑迫健二、曹 袁寧、北村和雄、江藤胤尚:アドレノメデュリン(AM)受容体のシャペロン蛋白である受容体活性調節蛋白(RAMP)アイソフォームの相異なる役割.第9回日本心血管内分泌代謝学会学術総会、2005年11月(東京)